Join Integra Connect's Kit Robertson RN, BSN, PMC-III and PatientPoint®'s Linda Ruschau on day 2 of Future Pharma for ‘Point of Care’s Role in the Evolution of Pharma Marketing’. This Roundtable explores how a Point of Care-first approach to digital marketing can help to improve outcomes for both patients and brands. Learn more https://bit.ly/3QUPo61
PatientPoint®’s Post
More Relevant Posts
-
Crafting Triumph: Real-World Evidence in Pharma • Navigating Nuances: Immerse into the intricate world of data-driven pharma decisions. • Data-Driven Decisions: Crafting triumph in every strategy with a backbone of real-world evidence. • Innovative Frontiers: Push the boundaries of what’s possible with Pi Pharma. #DataDrivenPharma #InnovativeFrontiers
To view or add a comment, sign in
-
ICYMI: In 2024, Pharma needs to consolidate the foundational work from previous years and continue to prioritize gaining a deeper understanding of HCPs' needs and behaviors. Learn more and discover five other trends for the year in our blog post. https://lnkd.in/g-4MWFwb
To view or add a comment, sign in
-
Join me and fellow marketers at Digital Pharma East 2024 (Sept. 9-12, Philadelphia, PA) as we shape the future of pharma marketing together. You will be with the Who’s Who in the pharma marketing industry. Register here: https://lnkd.in/e6RgZRqf #DPEAST #DigitalPharma #pharmamarketing #digitalmarketing #marketing #WeAreFierce Digital Pharma Series
To view or add a comment, sign in
-
Buckle up, pharma marketing innovators! The healthcare landscape is evolving at a breakneck speed, and one question echoes in every mind: What trends should pharma marketers be watching in 2024? We've tapped our most visionary leaders at OptimizeRx to share their predictions on the forces driving pharmaceutical marketing in the coming year, starting with our CEO, Will Febbo: "In 2024, I believe HCP marketing will truly become data-driven and clinical in orientation. HCPs have been vocal about their need for less 'spam' and more relevant, value-add brand information for decades. But today, the difference is that pharma can finally connect patient data to drive content relevancy, then deliver that content during specific care decision windows. As a result..." Read more: https://bit.ly/3tRRXgS
2024 Pharma Marketing Predictions: Better Execution Through Data and Technology
To view or add a comment, sign in
-
Embark on a journey through the ever-evolving landscape of pharmaceutical trends with our insightful infographic! From groundbreaking advancements in personalized medicine to the transformative power of digital health solutions, discover how pharma is revolutionizing healthcare delivery. Dive into key insights and stay ahead of the curve with our comprehensive guide. Read More: https://lnkd.in/dafWQRic #PharmaTrends #HealthcareInnovation #DigitalHealth
To view or add a comment, sign in
-
Discover the most up-to-date trends, challenges and opportunities affecting HCP engagement in 2024. Containing multi-stakeholder insights from healthcare professionals, pharma executives and service providers, our latest report on the Future of HCP Engagement Impact will help steer your strategy. Download the report - https://lnkd.in/ePCB4GxC #pharma #MedComms #HCPEngagement #MedicalAffairs
To view or add a comment, sign in
-
Discover the most up-to-date trends, challenges and opportunities affecting HCP engagement in 2024. Containing multi-stakeholder insights from healthcare professionals, pharma executives and service providers, our latest report on the Future of HCP Engagement Impact will help steer your strategy. Download the report - https://lnkd.in/ePCB4GxC #pharma #MedComms #HCPEngagement #MedicalAffairs
To view or add a comment, sign in
-
Check out my recent conversation with Amanda Powers Han of Greater Than One (also a member of the PE EAB!) about improving DE&I in healthcare marketing to reach diverse audiences on a deeper level. Listen below!
Amanda Powers Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more 🎙️ https://lnkd.in/e2q-Kzgc #pharmaceuticalmarketing #pharmamarketing #marketingandadvertising #diversityequityinclusion
To view or add a comment, sign in
-
Why it is important to deliver value-based content to HCP and how pharma companies should adjust to meet HCP needs. Florent Edouard - SVP, Global Head of Commercial Excellence Grünenthal Group Watch the full webinar recording "The self-detailing revolution" here: https://lnkd.in/dCzHWeZb #hcpengagement #pharma #customerengagement #pharmamarketing
To view or add a comment, sign in
-
Norstella's Daniel Chancellor opines on the essential big-picture dynamics in today's pharma landscape. With clinical advances benefitting previously overlooked patients, pharma companies are shifting how they build their pipelines and communicate value to payers. Deciding on the right strategies relies on accessing the best data, learning lessons from the past and looking into the future. And the winners of the future? Look to those trying to stand out from the crowd rather than just playing catch up to the latest industry trends. Click here to learn more about Norstella's brands, which work to help our clients connect the dots from pipeline to patient: https://ow.ly/SJ4t50RvRVM. #Pipeline2Patient #FollowNorstella #Pharma #PhamaceuticalIndustry #PharmaInsights
To view or add a comment, sign in
16,536 followers